| |
| |
|
| Insider
Information: |
Welch James H |
| Relationship: |
Chief Financial Officer |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
21,257 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$19,884 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
21,257 |
|
|
| Total
Value |
$19,884 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Rigel Pharmaceuticals Inc |
RIGL |
CFO, VP & Secretary |
2004-09-02 |
3,757 |
2003-07-31 |
0 |
Premium* |
|
|
Acelrx Pharmaceuticals Inc |
ACRX |
Chief Financial Officer |
2011-09-07 |
15,000 |
2011-09-06 |
0 |
Premium* |
|
|
Celladon Corp |
CLDN |
Chief Financial Officer |
2016-06-22 |
2,500 |
2016-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
7 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CLDN |
Celladon Corp |
Chief Financial Officer |
• – – |
2016-06-22 |
4 |
B |
$19.79 |
$9,897 |
D/D |
500 |
2,500 |
2.74 |
- |
|
| CLDN |
Celladon Corp |
Chief Financial Officer |
• – – |
2016-06-20 |
4 |
B |
$19.80 |
$39,592 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2011-09-07 |
4 |
B |
$3.39 |
$10,179 |
D/D |
3,000 |
15,000 |
2.74 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2011-09-06 |
4 |
B |
$3.32 |
$23,238 |
D/D |
7,000 |
12,000 |
2.74 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
CFO, VP & Secretary |
• – – |
2004-09-02 |
4 |
OE |
$1.80 |
$9,900 |
D/D |
5,500 |
13,757 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
CFO, VP & Secretary |
• – – |
2004-09-02 |
4 |
S |
$20.20 |
$202,308 |
D/D |
(10,000) |
3,757 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
officerTitle |
• – – |
2003-07-31 |
4 |
OE |
$5.76 |
$13,692 |
D/D |
2,377 |
7,365 |
|
- |
|
7 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
